Claraphi Advisory Network’s Moderna MRNA Stock Holding History

Claraphi Advisory Network’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,444	Closed	-$1.32M	–	318
2021 Q3	$1.32M	Buy	3,444 +693	+25%	+$256K	0.47%	42
2021 Q2	$647K	Buy	+2,751	New	+$492K	0.19%	117
2020 Q2	–	Sell	-332	Closed	-$10K	–	841
2020 Q1	$10K	Buy	+332	New	+$7.64K	﹤0.01%	769

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Claraphi Advisory Network's MRNA Position: Q4 2021 in Review

Claraphi Advisory Network sold out of Moderna (MRNA) in Q4 2021, closing a stake of 3,444 shares — an estimated $1.32M sold.

Claraphi Advisory Network first reported a position in MRNA in Q1 2020 and held it in 3 quarters. The position peaked at $1.32M in Q3 2021. 1,110 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

Claraphi Advisory Network reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
Claraphi Advisory Network sold 3,444 Moderna shares in Q4 2021, an estimated $1.32M.
Claraphi Advisory Network first reported a position in Moderna in Q1 2020 and held it in 3 quarters.
Claraphi Advisory Network's Moderna position peaked at $1.32M in Q3 2021.
1,110 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Claraphi Advisory Network's 13F filing for Q4 2021, filed 7 Feb 2022.